Insider plans sale of 13,109 CGON shares

CGON filed a notice of proposed sale of restricted or control securities.

Accepted by SEC EDGAR 01/09/2026 - 04:32 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

CGON filed a notice of proposed sale of restricted or control securities. The filing covers the planned sale of 13,109 common shares, with an aggregate market value of $549,660.37, through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of 01/09/2026. The issuer had 80,666,179 common shares outstanding. The shares to be sold were acquired on 01/09/2026 by exercising stock options granted by the issuer, paid for in cash on the same date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CGON Form 144 filing disclose?

The Form 144 discloses a planned sale of 13,109 shares of CGON common stock, acquired via stock option exercise and proposed to be sold on NASDAQ through a broker.

How many CGON shares are planned to be sold and what is their value?

The notice covers 13,109 common shares with an aggregate market value of $549,660.37.

How were the CGON shares being sold under Form 144 acquired?

The shares were acquired on 01/09/2026 through an exercise of stock options from the issuer, with the purchase price paid in cash on the same date.

Which broker is handling the planned CGON share sale?

The planned sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, New York, NY 10004.

On which exchange are the CGON shares intended to be sold?

The filing indicates that the common shares are intended to be sold on the NASDAQ stock market.

How many CGON shares were outstanding at the time referenced in the filing?

The Form 144 states that there were 80,666,179 common shares outstanding for the issuer.

What is the approximate date of the planned CGON share sale in this Form 144?

The approximate date of sale listed for the 13,109 common shares is 01/09/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001684531
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CG Oncology, Inc.
SEC File Number	001-41925
Address of Issuer	400 SPECTRUM CENTER DRIVE, SUITE 2040 IRVINE CALIFORNIA 92618
Phone	9494196203
Name of Person for Whose Account the Securities are To Be Sold	JAMES MULAY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	13109	549660.37	80666179	01/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/09/2026	Exercise of Stock Options	Issuer			13109	01/09/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	01/09/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/06/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Joseph Mulay
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)